Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedMar 8, 2023Pravastatin Sodium Tablets USPCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0421-2023Class IITerminatedMar 8, 2023Pirfenidone Tablets 801 mgCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0420-2023Class IITerminatedMar 8, 2023Pirfenidone Tablets 267 mgCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0419-2023Class IITerminatedMar 8, 2023Vigabatrin for Oral SolutionCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0418-2023Class IITerminatedMar 8, 2023Tadalafil TabletsCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0417-2023Class IITerminatedMar 8, 2023Tadalafil TabletsCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0416-2023Class IITerminatedMar 8, 2023Tadalafil TabletsCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0415-2023Class IITerminatedMar 8, 2023Tadalafil TabletsCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0414-2023Class IITerminatedMar 8, 2023Succinylcholine Chloride InjectionCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0413-2023Class IITerminatedMar 8, 2023Simvastatin Tablets USP 80 mgCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0412-2023Class IITerminatedMar 8, 2023Simvastatin Tablets USP 40 mgCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0411-2023Class IITerminatedMar 8, 2023Simvastatin Tablets USP 20 mgCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0410-2023Class IITerminatedMar 8, 2023Simvastatin TabletsCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0409-2023Class IITerminatedMar 8, 2023Simvastatin Tablets USP 5 mgCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0408-2023Class IITerminatedMar 8, 2023Rosuvastatin TabletsCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0407-2023Class IITerminatedMar 8, 2023Rosuvastatin TabletsCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0406-2023Class IITerminatedMar 8, 2023Rosuvastatin TabletsCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0405-2023Class IITerminatedMar 8, 2023Rosuvastatin TabletsCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0404-2023Class IITerminatedMar 8, 2023Phenylephrine Hydrochloride InjectionCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0403-2023Class IITerminatedMar 8, 2023Phenylephrine Hydrochloride InjectionCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0402-2023Class IITerminatedMar 8, 2023Phenylephrine Hydrochloride InjectionCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0401-2023Class IITerminatedMar 8, 2023Montelukast Sodium TabletsCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0400-2023Class IITerminatedMar 8, 2023Glycopyrrolate InjectionCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0399-2023Class IITerminatedMar 8, 2023Glycopyrrolate InjectionCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0398-2023Class IITerminatedMar 8, 2023Glycopyrrolate InjectionCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0397-2023Class IITerminatedMar 8, 2023Glycopyrrolate InjectionCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0396-2023Class IITerminatedMar 8, 2023Glimepiride Tablets USPCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0395-2023Class IITerminatedMar 8, 2023Glimepiride Tablets USPCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0394-2023Class IITerminatedMar 8, 2023Glimepiride Tablets USPCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0393-2023Class IITerminatedMar 8, 2023Finasteride Tablets USPCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0392-2023Class IITerminatedMar 8, 2023Finasteride Tablets USP 1 mgCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0391-2023Class IITerminatedMar 8, 2023Finasteride Tablets USPCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0390-2023Class IITerminatedMar 8, 2023Doxazosin Tablets USPCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0389-2023Class IITerminatedMar 8, 2023Doxazosin Tablets USPCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0388-2023Class IITerminatedMar 8, 2023Doxazosin Tablets USPCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0387-2023Class IITerminatedMar 8, 2023Doxazosin Tablets USP 1 mgCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0386-2023Class IITerminatedMar 8, 2023Dofetilide Capsules 500 mcgCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0385-2023Class IITerminatedMar 8, 2023Dofetilide Capsules 250 mcgCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0384-2023Class IITerminatedMar 8, 2023Dofetilide CapsulesCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0383-2023Class IITerminatedMar 8, 2023Daptomycin for Injection 500 mg per vialCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0382-2023